Category: Products & Treatment

Products & Treatment

Global Respiratory Societies Mark World Bronchiectasis Day 2026

On July 1, international organizations aim to increase awareness and research for bronchiectasis to improve patient outcomes and healthcare access.

Products & Treatment

FDA Clears Masimo’s Ai-Enabled OIRD Monitor

Masimo's Radius VSM wearable monitor uses pattern recognition to help ID early signs of opioid-induced respiratory depression (OIRD).

Products & Treatment

Capnography and Pulse Oximetry in the PICU

For patients in the pediatric ICU, pulse oximetry and waveform capnography are valuable tools to monitor the effectiveness of respiratory support and to inform treatment decisions.

Industry & Regulatory News

FDA Approves Generic Xofluza

The FDA approved the first generic of Xofluza (baloxavir marboxil) tablets, the first single-dose treatment for acute uncomplicated influenza and prophylaxis in patients 5 years of age and older.

Pharmaceuticals

Unique Attack Method for New Antibiotic

Researchers discovered manikomycin, a soil-derived peptide that attacks bacteria in a unique way to bypass existing antibiotic resistance.

Diagnostics & Testing

Wesper Launches Multi-tier Home Sleep Testing Platform

The ecosystem integrates two diagnostic levels into one patient record to help physicians personalize sleep apnea diagnostics and monitoring.

Monitoring & Treatment

[Featured Report] Overnight Pulse Oximetry

From assessing hypoxia and supplemental oxygen needs in respiratory patients to screening obstructive sleep apnea and evaluating dental sleep appliances, overnight pulse oximetry (OPO) offers noninvasive, cost-effective monitoring, as new technologies further streamline care.